Pharmanutra

Pharmanutra's reported carbon emissions

Pharmanutra, an Italian pharmaceutical preparation manufacturing company, reported a total of approximately 3.21 million kg CO2e in Scope 1 and 2 emissions for the 2024 reporting year. This figure includes approximately 0.22 million kg CO2e from Scope 1 and about 1.48 million kg CO2e from Scope 2 (market-based). For the same year, Scope 3 emissions, specifically fuel and energy-related activities, amounted to approximately 0.012 million kg CO2e. In the 2023 reporting year, Pharmanutra's total Scope 1 and 2 emissions were approximately 0.69 million kg CO2e, comprising about 0.23 million kg CO2e from Scope 1 and around 0.46 million kg CO2e from Scope 2 (market-based). Scope 3 emissions for fuel and energy-related activities were approximately 0.012 million kg CO2e. The company's emissions for the 2022 reporting year totalled approximately 0.29 million kg CO2e (Scope 1 and 2), with Scope 1 at approximately 0.20 million kg CO2e and Scope 2 at about 0.06 million kg CO2e (market-based). Scope 3 data was not disclosed for this year. In 2021, Pharmanutra reported Scope 1 emissions of approximately 0.14 million kg CO2e and Scope 2 emissions of approximately 0.04 million kg CO2e (market-based). Scope 3 data was not disclosed. For the 2020 reporting year, Scope 1 emissions were approximately 0.09 million kg CO2e and Scope 2 emissions were approximately 0.06 million kg CO2e (market-based). Scope 3 data was not disclosed. Pharmanutra has not publicly disclosed specific reduction targets or commitments at this time. The company's sustainability reports indicate that Scope 3 emissions, particularly purchased goods and services, are a missing data point in their current reporting.